Yatin Suneja
Stock Analyst at Guggenheim
(4.74)
# 142
Out of 5,150 analysts
161
Total ratings
61.11%
Success rate
30.6%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SION Sionna Therapeutics | Maintains: Buy | $45 → $50 | $34.09 | +46.67% | 1 | Mar 3, 2026 | |
| PHAT Phathom Pharmaceuticals | Maintains: Buy | $20 → $25 | $11.05 | +126.24% | 5 | Feb 27, 2026 | |
| ARGX argenx SE | Maintains: Buy | $1,160 → $1,120 | $748.72 | +49.59% | 14 | Feb 27, 2026 | |
| AXSM Axsome Therapeutics | Maintains: Buy | $205 → $220 | $164.05 | +34.11% | 10 | Feb 24, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $760 → $800 | $318.22 | +151.40% | 5 | Feb 10, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $865 → $975 | $766.66 | +27.18% | 9 | Feb 9, 2026 | |
| BIIB Biogen | Maintains: Buy | $185 → $246 | $184.02 | +33.68% | 4 | Feb 9, 2026 | |
| ROIV Roivant Sciences | Maintains: Buy | $28 → $30 | $27.85 | +7.72% | 4 | Feb 9, 2026 | |
| IMVT Immunovant | Maintains: Buy | $41 → $44 | $26.71 | +64.73% | 9 | Feb 9, 2026 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $50 | $18.85 | +165.25% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $32 | $28.15 | +13.68% | 3 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.89 | +285.60% | 1 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $51 | $21.87 | +133.20% | 2 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $22 | $0.91 | +2,311.22% | 6 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $100 | $52.83 | +89.29% | 14 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $14 | $3.06 | +357.52% | 3 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $58.01 | +20.67% | 4 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $32.84 | +82.70% | 1 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $150 | $111.10 | +35.01% | 3 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $112 → $128 | $7.02 | +1,723.36% | 3 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $20 | $17.69 | +13.06% | 4 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $100 | $55.45 | +80.34% | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $30.42 | +146.55% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $15 | $3.25 | +361.54% | 6 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $175 | $131.14 | +33.45% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $5.51 | +371.87% | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $29 | $15.30 | +89.54% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.49 | +131.12% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $25.18 | +78.71% | 3 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 | $26.45 | +70.16% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 | $22.50 | -11.11% | 6 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.89 | - | 2 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $65 | $40.07 | +62.22% | 1 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $28.94 | +210.99% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.60 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $43.79 | +11.90% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $18.32 | +200.22% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.67 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $17.98 | +33.48% | 1 | May 31, 2022 |
Sionna Therapeutics
Mar 3, 2026
Maintains: Buy
Price Target: $45 → $50
Current: $34.09
Upside: +46.67%
Phathom Pharmaceuticals
Feb 27, 2026
Maintains: Buy
Price Target: $20 → $25
Current: $11.05
Upside: +126.24%
argenx SE
Feb 27, 2026
Maintains: Buy
Price Target: $1,160 → $1,120
Current: $748.72
Upside: +49.59%
Axsome Therapeutics
Feb 24, 2026
Maintains: Buy
Price Target: $205 → $220
Current: $164.05
Upside: +34.11%
Praxis Precision Medicines
Feb 10, 2026
Maintains: Buy
Price Target: $760 → $800
Current: $318.22
Upside: +151.40%
Regeneron Pharmaceuticals
Feb 9, 2026
Maintains: Buy
Price Target: $865 → $975
Current: $766.66
Upside: +27.18%
Biogen
Feb 9, 2026
Maintains: Buy
Price Target: $185 → $246
Current: $184.02
Upside: +33.68%
Roivant Sciences
Feb 9, 2026
Maintains: Buy
Price Target: $28 → $30
Current: $27.85
Upside: +7.72%
Immunovant
Feb 9, 2026
Maintains: Buy
Price Target: $41 → $44
Current: $26.71
Upside: +64.73%
Avalo Therapeutics
Feb 2, 2026
Initiates: Buy
Price Target: $50
Current: $18.85
Upside: +165.25%
Jan 7, 2026
Maintains: Buy
Price Target: $18 → $32
Current: $28.15
Upside: +13.68%
Dec 19, 2025
Initiates: Buy
Price Target: $15
Current: $3.89
Upside: +285.60%
Dec 17, 2025
Maintains: Buy
Price Target: $35 → $51
Current: $21.87
Upside: +133.20%
Nov 10, 2025
Maintains: Buy
Price Target: $10 → $22
Current: $0.91
Upside: +2,311.22%
Nov 5, 2025
Maintains: Buy
Price Target: $90 → $100
Current: $52.83
Upside: +89.29%
Oct 27, 2025
Upgrades: Buy
Price Target: $14
Current: $3.06
Upside: +357.52%
Oct 27, 2025
Initiates: Buy
Price Target: $70
Current: $58.01
Upside: +20.67%
Oct 27, 2025
Initiates: Buy
Price Target: $60
Current: $32.84
Upside: +82.70%
Oct 10, 2025
Maintains: Buy
Price Target: $101 → $150
Current: $111.10
Upside: +35.01%
Oct 8, 2025
Maintains: Buy
Price Target: $112 → $128
Current: $7.02
Upside: +1,723.36%
Sep 30, 2025
Maintains: Buy
Price Target: $80 → $20
Current: $17.69
Upside: +13.06%
Sep 9, 2025
Maintains: Buy
Price Target: $92 → $100
Current: $55.45
Upside: +80.34%
Aug 18, 2025
Initiates: Buy
Price Target: $75
Current: $30.42
Upside: +146.55%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $15
Current: $3.25
Upside: +361.54%
Aug 1, 2025
Maintains: Buy
Price Target: $165 → $175
Current: $131.14
Upside: +33.45%
Jun 25, 2025
Reiterates: Buy
Price Target: $26
Current: $5.51
Upside: +371.87%
May 9, 2025
Maintains: Buy
Price Target: $32 → $29
Current: $15.30
Upside: +89.54%
Mar 26, 2025
Reiterates: Buy
Price Target: $15
Current: $6.49
Upside: +131.12%
Mar 12, 2025
Reiterates: Buy
Price Target: $45
Current: $25.18
Upside: +78.71%
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $26.45
Upside: +70.16%
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $22.50
Upside: -11.11%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.89
Upside: -
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $40.07
Upside: +62.22%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $28.94
Upside: +210.99%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.60
Upside: -
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $43.79
Upside: +11.90%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $18.32
Upside: +200.22%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.67
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $17.98
Upside: +33.48%